gland-pharma-receives-usfda-approval-for-eribulin-mesylate-injection News in Hindi -1 News Headlines Found

Gland Pharma receives USFDA approval for Eribulin Mesylate Injection

Hyderabad, Apr 8 (UNI) Gland Pharma Limited, a generic injectable-focused pharmaceutical company, has received approval from the United States Food and Drug Administration (USFDA) for Eribulin Mesylate Injection, 0.5 mg/mL Single Dose Vial (Product).

#Gland Pharma receives USFDA approval for Eribulin Mesylate Injection

gland pharma receives usfda approval for eribulin mesylate injection- Latest Hindi News headlines on gland pharma receives usfda approval for eribulin mesylate injection. Stay updated with recent developments & news stories about gland pharma receives usfda approval for eribulin mesylate injection